Skip to main content
Top
Published in: Cardiovascular Diabetology 1/2016

Open Access 01-12-2016 | Original investigation

Diabetes is an independent predictor of right ventricular dysfunction post ST-elevation myocardial infarction

Authors: Idan Roifman, Nilesh Ghugre, Mohammad I. Zia, Michael E. Farkouh, Anna Zavodni, Graham A. Wright, Kim A. Connelly

Published in: Cardiovascular Diabetology | Issue 1/2016

Login to get access

Abstract

Background

Diabetes mellitus (DM) is estimated to become the 7th leading cause of death by 2030. Right ventricular dysfunction (RVD) complicating ST elevation myocardial infarction (STEMI) is independently associated with a higher mortality; however the relationship between DM and RVD is currently unknown. The purpose of this study was to determine whether DM is an independent predictor for the presence of right ventricular dysfunction (RVD) post STEMI.

Methods

106 patients post primary PCI for STEMI were enrolled in the study. Cardiac MRI was performed within 48–72 h after admission in order to assess ventricular function. Statistical analysis consisted initially of descriptive statistics including Chi square, Fisher’s exact, or the Wilcoxon rank sum as appropriate. Subsequently, logistic regression analysis was performed to determine independent predictors of RVD.

Results

The median age in the study was 58 years (IQR 53, 67). 30 % of the patients had diabetes. Of 99 patients for which RV data was available, 40 had RVD and 59 did not. Patients with DM were significantly more likely to have RVD when compared to those without diabetes (45 vs 22 %, p = 0.03). There was no significant difference in age, hypertension, smoking status, dyslipidemia, serum creatinine or peak CK levels between the two groups. After adjusting for other factors, presence of DM remained an independent predictor for the presence of RV dysfunction (OR 2.78, 95 % CI 1.12, 6.87, p = 0.03). Amongst diabetic patients, those with HbA1C ≥ 7 % had greater odds of having RVD vs those with HbA1C < 7 % (OR 5.58 (1.20, 25.78), p = 0.02).

Conclusions

The presence of DM conferred an approximately threefold greater odds of being associated with RVD post STEMI. No other major cardiovascular risk factors were independently associated with the presence of RVD.
Appendix
Available only for authorised users
Literature
2.
go back to reference Malmberg K, Yusuf S, Gerstein HC, Brown J, Zhao F, Hunt D, et al. Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction: results of the OASIS (Organization to assess strategies for ischemic syndromes) Registry. Circulation. 2000;102(9):1014–9.CrossRefPubMed Malmberg K, Yusuf S, Gerstein HC, Brown J, Zhao F, Hunt D, et al. Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction: results of the OASIS (Organization to assess strategies for ischemic syndromes) Registry. Circulation. 2000;102(9):1014–9.CrossRefPubMed
3.
4.
go back to reference Tocci G, Ferrucci A, Guida P, Avogaro A, Comaschi M, Corsini A, et al. Impact of diabetes mellitus on the clinical management of global cardiovascular risk: analysis of the results of the evaluation of final feasible effect of control training and ultra sensitization (EFFECTUS) educational program. Clin Cardiol. 2011;34(9):560–6. doi:10.1002/clc.20937.CrossRefPubMed Tocci G, Ferrucci A, Guida P, Avogaro A, Comaschi M, Corsini A, et al. Impact of diabetes mellitus on the clinical management of global cardiovascular risk: analysis of the results of the evaluation of final feasible effect of control training and ultra sensitization (EFFECTUS) educational program. Clin Cardiol. 2011;34(9):560–6. doi:10.​1002/​clc.​20937.CrossRefPubMed
8.
go back to reference Ondrus T, Kanovsky J, Novotny T, Andrsova I, Spinar J, Kala P. Right ventricular myocardial infarction: from pathophysiology to prognosis. Exp Clinical Cardiol. 2013;18(1):27–30. Ondrus T, Kanovsky J, Novotny T, Andrsova I, Spinar J, Kala P. Right ventricular myocardial infarction: from pathophysiology to prognosis. Exp Clinical Cardiol. 2013;18(1):27–30.
10.
go back to reference Klein R, Klein BE, Moss SE, Cruickshanks KJ. Relationship of hyperglycemia to the long-term incidence and progression of diabetic retinopathy. Arch Intern Med. 1994;154(19):2169–78.CrossRefPubMed Klein R, Klein BE, Moss SE, Cruickshanks KJ. Relationship of hyperglycemia to the long-term incidence and progression of diabetic retinopathy. Arch Intern Med. 1994;154(19):2169–78.CrossRefPubMed
12.
go back to reference Di Carli MF, Janisse J, Grunberger G, Ager J. Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in diabetes. J Am Col Cardiol. 2003;41(8):1387–93.CrossRef Di Carli MF, Janisse J, Grunberger G, Ager J. Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in diabetes. J Am Col Cardiol. 2003;41(8):1387–93.CrossRef
14.
go back to reference O’Gara PT, Kushner FG, Ascheim DD, Casey DE Jr, Chung MK, de Lemos JA, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Col Cardiol. 2013;61(4):e78–140. doi:10.1016/j.jacc.2012.11.019.CrossRef O’Gara PT, Kushner FG, Ascheim DD, Casey DE Jr, Chung MK, de Lemos JA, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Col Cardiol. 2013;61(4):e78–140. doi:10.​1016/​j.​jacc.​2012.​11.​019.CrossRef
15.
go back to reference O’Gara PT, Kushner FG, Ascheim DD, Casey DE Jr, Chung MK, de Lemos JA, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;127(4):e362–425. doi:10.1161/CIR.0b013e3182742cf6.CrossRefPubMed O’Gara PT, Kushner FG, Ascheim DD, Casey DE Jr, Chung MK, de Lemos JA, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;127(4):e362–425. doi:10.​1161/​CIR.​0b013e3182742cf6​.CrossRefPubMed
16.
go back to reference Schulz-Menger J, Bluemke DA, Bremerich J, Flamm SD, Fogel MA, Friedrich MG, et al. Standardized image interpretation and post processing in cardiovascular magnetic resonance: Society for Cardiovascular Magnetic Resonance (SCMR) board of trustees task force on standardized post processing. J Cardiovasc Magn Reson. 2013;15:35. doi:10.1186/1532-429X-15-35.PubMedCentralCrossRefPubMed Schulz-Menger J, Bluemke DA, Bremerich J, Flamm SD, Fogel MA, Friedrich MG, et al. Standardized image interpretation and post processing in cardiovascular magnetic resonance: Society for Cardiovascular Magnetic Resonance (SCMR) board of trustees task force on standardized post processing. J Cardiovasc Magn Reson. 2013;15:35. doi:10.​1186/​1532-429X-15-35.PubMedCentralCrossRefPubMed
17.
go back to reference Roifman I, Zia MI, Zavodni A, Wolff R, Ghugre NR, Leber AW, et al. Evolution of right ventricular function post-acute ST elevation myocardial infarction. J Magn Reson Imaging. 2014;40(3):709–14. doi:10.1002/jmri.24402.CrossRefPubMed Roifman I, Zia MI, Zavodni A, Wolff R, Ghugre NR, Leber AW, et al. Evolution of right ventricular function post-acute ST elevation myocardial infarction. J Magn Reson Imaging. 2014;40(3):709–14. doi:10.​1002/​jmri.​24402.CrossRefPubMed
18.
go back to reference Pavlicek M, Wahl A, Rutz T, de Marchi SF, Hille R, Wustmann K, et al. Right ventricular systolic function assessment: rank of echocardiographic methods vs cardiac magnetic resonance imaging. Eur J. 2011;12(11):871–80. doi:10.1093/ejechocard/jer138. Pavlicek M, Wahl A, Rutz T, de Marchi SF, Hille R, Wustmann K, et al. Right ventricular systolic function assessment: rank of echocardiographic methods vs cardiac magnetic resonance imaging. Eur J. 2011;12(11):871–80. doi:10.​1093/​ejechocard/​jer138.
19.
go back to reference Wahl A, Praz F, Schwerzmann M, Bonel H, Koestner SC, Hullin R, et al. Assessment of right ventricular systolic function: comparison between cardiac magnetic resonance derived ejection fraction and pulsed-wave tissue Doppler imaging of the tricuspid annulus. Int J Cardiol. 2011;151(1):58–62. doi:10.1016/j.ijcard.2010.04.089.CrossRefPubMed Wahl A, Praz F, Schwerzmann M, Bonel H, Koestner SC, Hullin R, et al. Assessment of right ventricular systolic function: comparison between cardiac magnetic resonance derived ejection fraction and pulsed-wave tissue Doppler imaging of the tricuspid annulus. Int J Cardiol. 2011;151(1):58–62. doi:10.​1016/​j.​ijcard.​2010.​04.​089.CrossRefPubMed
20.
go back to reference Movahed MR, Milne N. Poor correlation between left and right ventricular ejection fractions in patients with normal ventricular function. Exp Clin Cardiol. 2008;13(4):179–81.PubMedCentralPubMed Movahed MR, Milne N. Poor correlation between left and right ventricular ejection fractions in patients with normal ventricular function. Exp Clin Cardiol. 2008;13(4):179–81.PubMedCentralPubMed
21.
go back to reference Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364(9438):937–52. doi:10.1016/S0140-6736(04)17018-9.CrossRefPubMed Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364(9438):937–52. doi:10.​1016/​S0140-6736(04)17018-9.CrossRefPubMed
22.
go back to reference Yoshida M, Mita T, Yamamoto R, Shimizu T, Ikeda F, Ohmura C, et al. Combination of the Framingham risk score and carotid intima-media thickness improves the prediction of cardiovascular events in patients with type 2 diabetes. Diabetes Care. 2012;35(1):178–80. doi:10.2337/dc11-1333.PubMedCentralCrossRefPubMed Yoshida M, Mita T, Yamamoto R, Shimizu T, Ikeda F, Ohmura C, et al. Combination of the Framingham risk score and carotid intima-media thickness improves the prediction of cardiovascular events in patients with type 2 diabetes. Diabetes Care. 2012;35(1):178–80. doi:10.​2337/​dc11-1333.PubMedCentralCrossRefPubMed
24.
go back to reference Masci PG, Francone M, Desmet W, Ganame J, Todiere G, Donato R, et al. Right ventricular ischemic injury in patients with acute ST-segment elevation myocardial infarction: characterization with cardiovascular magnetic resonance. Circulation. 2010;122(14):1405–12. doi:10.1161/CIRCULATIONAHA.110.940254.CrossRefPubMed Masci PG, Francone M, Desmet W, Ganame J, Todiere G, Donato R, et al. Right ventricular ischemic injury in patients with acute ST-segment elevation myocardial infarction: characterization with cardiovascular magnetic resonance. Circulation. 2010;122(14):1405–12. doi:10.​1161/​CIRCULATIONAHA.​110.​940254.CrossRefPubMed
25.
go back to reference Grothoff M, Elpert C, Hoffmann J, Zachrau J, Lehmkuhl L, de Waha S, et al. Right ventricular injury in ST-elevation myocardial infarction: risk stratification by visualization of wall motion, edema, and delayed-enhancement cardiac magnetic resonance. Circ Cardiovasc Imaging. 2012;5(1):60–8. doi:10.1161/CIRCIMAGING.111.967810.CrossRefPubMed Grothoff M, Elpert C, Hoffmann J, Zachrau J, Lehmkuhl L, de Waha S, et al. Right ventricular injury in ST-elevation myocardial infarction: risk stratification by visualization of wall motion, edema, and delayed-enhancement cardiac magnetic resonance. Circ Cardiovasc Imaging. 2012;5(1):60–8. doi:10.​1161/​CIRCIMAGING.​111.​967810.CrossRefPubMed
26.
go back to reference Aschauer S, Kammerlander AA, Zotter-Tufaro C, Ristl R, Pfaffenberger S, Bachmann A, et al. The right heart in heart failure with preserved ejection fraction: insights from cardiac magnetic resonance imaging and invasive haemodynamics. Eur J Heart Fail. 2016;18(1):71–80. doi:10.1002/ejhf.418.CrossRefPubMed Aschauer S, Kammerlander AA, Zotter-Tufaro C, Ristl R, Pfaffenberger S, Bachmann A, et al. The right heart in heart failure with preserved ejection fraction: insights from cardiac magnetic resonance imaging and invasive haemodynamics. Eur J Heart Fail. 2016;18(1):71–80. doi:10.​1002/​ejhf.​418.CrossRefPubMed
27.
go back to reference Zehender M, Kasper W, Kauder E, Schonthaler M, Geibel A, Olschewski M, et al. Right ventricular infarction as an independent predictor of prognosis after acute inferior myocardial infarction. N Engl J Med. 1993;328(14):981–8. doi:10.1056/NEJM199304083281401.CrossRefPubMed Zehender M, Kasper W, Kauder E, Schonthaler M, Geibel A, Olschewski M, et al. Right ventricular infarction as an independent predictor of prognosis after acute inferior myocardial infarction. N Engl J Med. 1993;328(14):981–8. doi:10.​1056/​NEJM199304083281​401.CrossRefPubMed
28.
go back to reference Mehta SR, Eikelboom JW, Natarajan MK, Diaz R, Yi C, Gibbons RJ, et al. Impact of right ventricular involvement on mortality and morbidity in patients with inferior myocardial infarction. J Am Col Cardiol. 2001;37(1):37–43.CrossRef Mehta SR, Eikelboom JW, Natarajan MK, Diaz R, Yi C, Gibbons RJ, et al. Impact of right ventricular involvement on mortality and morbidity in patients with inferior myocardial infarction. J Am Col Cardiol. 2001;37(1):37–43.CrossRef
29.
go back to reference Jacobs AK, Leopold JA, Bates E, Mendes LA, Sleeper LA, White H, et al. Cardiogenic shock caused by right ventricular infarction: a report from the shock registry. J Am Col Cardiol. 2003;41(8):1273–9.CrossRef Jacobs AK, Leopold JA, Bates E, Mendes LA, Sleeper LA, White H, et al. Cardiogenic shock caused by right ventricular infarction: a report from the shock registry. J Am Col Cardiol. 2003;41(8):1273–9.CrossRef
30.
go back to reference Miszalski-Jamka T, Klimeczek P, Tomala M, Krupinski M, Zawadowski G, Noelting J, et al. Extent of RV dysfunction and myocardial infarction assessed by CMR are independent outcome predictors early after STEMI treated with primary angioplasty. JACC Cardiovasc Imaging. 2010;3(12):1237–46. doi:10.1016/j.jcmg.2010.09.018.CrossRefPubMed Miszalski-Jamka T, Klimeczek P, Tomala M, Krupinski M, Zawadowski G, Noelting J, et al. Extent of RV dysfunction and myocardial infarction assessed by CMR are independent outcome predictors early after STEMI treated with primary angioplasty. JACC Cardiovasc Imaging. 2010;3(12):1237–46. doi:10.​1016/​j.​jcmg.​2010.​09.​018.CrossRefPubMed
31.
go back to reference Larose E, Ganz P, Reynolds HG, Dorbala S, Di Carli MF, Brown KA, et al. Right ventricular dysfunction assessed by cardiovascular magnetic resonance imaging predicts poor prognosis late after myocardial infarction. J Am Col Cardiol. 2007;49(8):855–62. doi:10.1016/j.jacc.2006.10.056.CrossRef Larose E, Ganz P, Reynolds HG, Dorbala S, Di Carli MF, Brown KA, et al. Right ventricular dysfunction assessed by cardiovascular magnetic resonance imaging predicts poor prognosis late after myocardial infarction. J Am Col Cardiol. 2007;49(8):855–62. doi:10.​1016/​j.​jacc.​2006.​10.​056.CrossRef
32.
go back to reference Markiewicz W, Sechtem U, Higgins CB. Evaluation of the right ventricle by magnetic resonance imaging. Am Heart J. 1987;113(1):8–15.CrossRefPubMed Markiewicz W, Sechtem U, Higgins CB. Evaluation of the right ventricle by magnetic resonance imaging. Am Heart J. 1987;113(1):8–15.CrossRefPubMed
34.
go back to reference Anavekar NS, Skali H, Bourgoun M, Ghali JK, Kober L, Maggioni AP, et al. Usefulness of right ventricular fractional area change to predict death, heart failure, and stroke following myocardial infarction (from the VALIANT ECHO study). Am J Cardiol. 2008;101(5):607–12. doi:10.1016/j.amjcard.2007.09.115.CrossRefPubMed Anavekar NS, Skali H, Bourgoun M, Ghali JK, Kober L, Maggioni AP, et al. Usefulness of right ventricular fractional area change to predict death, heart failure, and stroke following myocardial infarction (from the VALIANT ECHO study). Am J Cardiol. 2008;101(5):607–12. doi:10.​1016/​j.​amjcard.​2007.​09.​115.CrossRefPubMed
35.
go back to reference Zornoff LA, Skali H, Pfeffer MA, St John Sutton M, Rouleau JL, Lamas GA, et al. Right ventricular dysfunction and risk of heart failure and mortality after myocardial infarction. J Am Col Cardiol. 2002;39(9):1450–5.CrossRef Zornoff LA, Skali H, Pfeffer MA, St John Sutton M, Rouleau JL, Lamas GA, et al. Right ventricular dysfunction and risk of heart failure and mortality after myocardial infarction. J Am Col Cardiol. 2002;39(9):1450–5.CrossRef
38.
39.
go back to reference Topol EJ, Califf RM, Kereiakes DJ, George BS. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) trial. J Am Col Cardiol. 1987;10(5):65–74.CrossRef Topol EJ, Califf RM, Kereiakes DJ, George BS. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) trial. J Am Col Cardiol. 1987;10(5):65–74.CrossRef
40.
go back to reference Duce SL, Weir-McCall JR, Gandy SJ, Matthew SZ, Cassidy DB, McCormick L, et al. Cohort comparison study of cardiac disease and atherosclerotic burden in type 2 diabetic adults using whole body cardiovascular magnetic resonance imaging. Cardiovasc Diabetol. 2015;14:122. doi:10.1186/s12933-015-0284-2.PubMedCentralCrossRefPubMed Duce SL, Weir-McCall JR, Gandy SJ, Matthew SZ, Cassidy DB, McCormick L, et al. Cohort comparison study of cardiac disease and atherosclerotic burden in type 2 diabetic adults using whole body cardiovascular magnetic resonance imaging. Cardiovasc Diabetol. 2015;14:122. doi:10.​1186/​s12933-015-0284-2.PubMedCentralCrossRefPubMed
41.
42.
43.
go back to reference Bonanad C, Ruiz-Sauri A, Forteza MJ, Chaustre F, Minana G, Gomez C, et al. Microvascular obstruction in the right ventricle in reperfused anterior myocardial infarction. Macroscopic and pathologic evidence in a swine model. Thromb Res. 2013;132(5):592–8. doi:10.1016/j.thromres.2013.08.009.CrossRefPubMed Bonanad C, Ruiz-Sauri A, Forteza MJ, Chaustre F, Minana G, Gomez C, et al. Microvascular obstruction in the right ventricle in reperfused anterior myocardial infarction. Macroscopic and pathologic evidence in a swine model. Thromb Res. 2013;132(5):592–8. doi:10.​1016/​j.​thromres.​2013.​08.​009.CrossRefPubMed
44.
go back to reference Voelkel NF, Quaife RA, Leinwand LA, Barst RJ, McGoon MD, Meldrum DR, et al. Right ventricular function and failure: report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure. Circulation. 2006;114(17):1883–91. doi:10.1161/CIRCULATIONAHA.106.632208.CrossRefPubMed Voelkel NF, Quaife RA, Leinwand LA, Barst RJ, McGoon MD, Meldrum DR, et al. Right ventricular function and failure: report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure. Circulation. 2006;114(17):1883–91. doi:10.​1161/​CIRCULATIONAHA.​106.​632208.CrossRefPubMed
45.
go back to reference Tomai F, Ribichini F, Ghini AS, Ferrero V, Ando G, Vassanelli C, et al. Elevated C-reactive protein levels and coronary microvascular dysfunction in patients with coronary artery disease. Eur Heart J. 2005;26(20):2099–105. doi:10.1093/eurheartj/ehi356.CrossRefPubMed Tomai F, Ribichini F, Ghini AS, Ferrero V, Ando G, Vassanelli C, et al. Elevated C-reactive protein levels and coronary microvascular dysfunction in patients with coronary artery disease. Eur Heart J. 2005;26(20):2099–105. doi:10.​1093/​eurheartj/​ehi356.CrossRefPubMed
Metadata
Title
Diabetes is an independent predictor of right ventricular dysfunction post ST-elevation myocardial infarction
Authors
Idan Roifman
Nilesh Ghugre
Mohammad I. Zia
Michael E. Farkouh
Anna Zavodni
Graham A. Wright
Kim A. Connelly
Publication date
01-12-2016
Publisher
BioMed Central
Published in
Cardiovascular Diabetology / Issue 1/2016
Electronic ISSN: 1475-2840
DOI
https://doi.org/10.1186/s12933-016-0352-2

Other articles of this Issue 1/2016

Cardiovascular Diabetology 1/2016 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.